Jump Financial, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Oct 21, 2024	BUY	$2.15 - $3.49 $2,322 - $3,769	1,080 Added 5.93%	19,280 $44,000
Q2 2023 Aug 07, 2023	BUY	$2.15 - $3.49 $2,322 - $3,769	1,080 Added 5.93%	19,280 $44,000
Q1 2023 Oct 21, 2024	BUY	$1.99 - $2.68 $36,218 - $48,776	18,200 New	18,200 $44,000
Q1 2023 May 03, 2023	BUY	$1.99 - $2.68 $36,218 - $48,776	18,200 New	18,200 $44,000
Q1 2022 May 12, 2022	SELL	$1.95 - $3.89 $75,465 - $150,543	-38,700 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$3.81 - $6.16 $147,447 - $238,392	38,700 New	38,700 $152,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $185M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.